Subscription to The Medical Letter
The Medical Letter On Drugs and Therapeutics is a biweekly publication that provides:
  • Evidence-based, peer-reviewed evaluations of new FDA-approved drugs with conclusions reached by a consensus of experts
  • New information on previously approved drugs including pivotal clinical trials, new indications, and safety warnings
  • Consensus recommendations for the preferred and alternative treatments for common disorders
  • Comparative reviews of drugs for a given indication with particular attention to clinical efficacy, adverse effects, drug interactions, and cost
Watch the video!
View Sample Issues: English, Canadian English, French Canadian
Reader Testimonials
Our editorial process relies on a consensus of experts to ensure the information in our articles is presented in a balanced and scientifically supported manner.
Subscriptions to The Medical Letter include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE – Up to 52 credits annually, including ABIM MOC points
Select an Option
For personal use only. Excludes corporate and institutional use.
The Medical Letter Site License
For corporate and institutional use.
Other Medical Letter Products:
Discover potentially life-threatening interactions. Subscribe to Drug Interactions from The Medical Letter.
Earn up to 52 CME/CE credits/year. Purchase CME/CE Exams.
Want to stay organized? Get a personalized Binder to hold your newsletters.
Want to have physical copies of past issues? Purchase a Bound Volume.